Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors. 2013

Anna Bielenica, and Anna E Kozioł, and Marta Struga

An overview of docking models of chain arylpiperazines to different subtypes of serotonin receptors belonging to the GPCR family is presented. The theory of a ligand-receptor interaction has been briefly summarized. The review covers more than twenty models, beginning with the early models of a ligand interaction with the 5-HT1A and 5-HT2A receptor, and ending with a ligand-5-HT7 receptor docking studies.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D044282 Receptor, Serotonin, 5-HT1A A serotonin receptor subtype found distributed through the CENTRAL NERVOUS SYSTEM where they are involved in neuroendocrine regulation of ACTH secretion. The fact that this serotonin receptor subtype is particularly sensitive to SEROTONIN RECEPTOR AGONISTS such as BUSPIRONE suggests its role in the modulation of ANXIETY and DEPRESSION. Serotonin 1A Receptor,5-HT(1A) Receptor,5-HT1A Receptor,5-Hydroxytryptamine 1A Receptor,5-Hydroxytryptamine 1A Receptors,Receptor, 5-Hydroxytryptamine 1A,Serotonin Receptor, 5-HT1A,Serotonin, 5-HT1a Receptor,1A Receptor, 5-Hydroxytryptamine,1A Receptors, 5-Hydroxytryptamine,5 HT1A Receptor,5 Hydroxytryptamine 1A Receptor,5 Hydroxytryptamine 1A Receptors,5-HT1A Serotonin Receptor,5-HT1a Receptor Serotonin,Receptor Serotonin, 5-HT1a,Receptor, 5 Hydroxytryptamine 1A,Receptor, 5-HT1A,Receptor, 5-HT1A Serotonin,Receptor, Serotonin 1A,Receptors, 5-Hydroxytryptamine 1A,Serotonin Receptor, 5 HT1A,Serotonin, 5 HT1a Receptor
D044402 Receptor, Serotonin, 5-HT2A A serotonin receptor subtype found widely distributed in peripheral tissues where it mediates the contractile responses of variety of tissues that contain SMOOTH MUSCLE. Selective 5-HT2A receptor antagonists include KETANSERIN. The 5-HT2A subtype is also located in BASAL GANGLIA and CEREBRAL CORTEX of the BRAIN where it mediates the effects of HALLUCINOGENS such as LSD. Serotonin 2A Receptor,5-HT(2A) Receptor,5-HT2A Receptor,Receptor, Serotonin 2A,Serotonin 2A Receptors,5 HT2A Receptor,Receptor, 5-HT2A,Receptors, Serotonin 2A
D058825 Serotonin 5-HT1 Receptor Agonists Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. 5-HT1 Agonists,5-HT1 Agonist,5-HT1A Agonist,5-HT1B Agonist,5-HT1B-D Agonist,5-HT1D Agonist,Serotonin 5-HT1A Receptor Agonists,Serotonin 5-HT1B Receptor Agonists,Serotonin 5-HT1B-D Agonists,Serotonin 5-HT1D Receptor Agonists,5 HT1 Agonist,5 HT1 Agonists,5 HT1A Agonist,5 HT1B Agonist,5 HT1B D Agonist,5 HT1D Agonist,5-HT1B-D Agonists, Serotonin,Agonist, 5-HT1,Agonist, 5-HT1A,Agonist, 5-HT1B,Agonist, 5-HT1B-D,Agonist, 5-HT1D,Agonists, 5-HT1,Agonists, Serotonin 5-HT1B-D,Serotonin 5 HT1 Receptor Agonists,Serotonin 5 HT1A Receptor Agonists,Serotonin 5 HT1B D Agonists,Serotonin 5 HT1B Receptor Agonists,Serotonin 5 HT1D Receptor Agonists

Related Publications

Anna Bielenica, and Anna E Kozioł, and Marta Struga
February 2001, Pharmacological research,
Anna Bielenica, and Anna E Kozioł, and Marta Struga
May 2012, Neuroreport,
Anna Bielenica, and Anna E Kozioł, and Marta Struga
August 2009, Behavioural brain research,
Anna Bielenica, and Anna E Kozioł, and Marta Struga
July 2014, CNS neuroscience & therapeutics,
Anna Bielenica, and Anna E Kozioł, and Marta Struga
July 2004, Journal of psychiatry & neuroscience : JPN,
Anna Bielenica, and Anna E Kozioł, and Marta Struga
July 2009, Brain : a journal of neurology,
Anna Bielenica, and Anna E Kozioł, and Marta Struga
January 2012, Current medicinal chemistry,
Anna Bielenica, and Anna E Kozioł, and Marta Struga
July 2004, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!